Drug Addiction

Supervised drug use proponents trudge onward

Supervised drug use proponents trudge onward

Some appear undaunted by legal hurdles

By Andy Metzger Andrew Lelling, Cindy Friedman, Fred Ryan, Jeff Roy, Jessie Gaeta, Marc McGovern, Marylou Sudders, Opioids, supervised drug use 0 Comments Jul 25, 2019

MARYLOU SUDDERS, the governor’s secretary of health and human services, led a state commission that concluded supervised drug consumption sites would be useful tools for Massachusetts because they prevent overdose deaths and stem the spread of disease. But it’s never been clear how far she would go to launch the sites, given that US Attorney(...)

Interstate finger-pointing after deadly crash

Case underscores high stakes of driving record systems

Andy Metzger

Surgeons over-prescribed opioids, report says

Medicare database shows prescriptions for various procedures

Bruce Mohl

Fighting opioids in the court and streets

AG announces big drug bust; Healey and Baker pen op-ed

Sarah Betancourt

Fighting opioids in the court and streets

CommonWealth Staff

Healey, Baker respond to Purdue in joint letter

Say company deceived prescribers and patients about its opioids

Matt Murphy

Time to rein in prescription drug costs

Profits yes, but not unchecked profits at expense of patients

Amy Rosenthal

MassBIO’s drug pricing concerns don’t add up

Big pharma should stop making threats about leaving

Paul A. Hattis

Health panel wants to open ‘black box’ of drug brokers

Agency joins chorus seeking greater pricing transparency

Andy Metzger

RFK, Jr.’s anti-vaccine campaign is reckless and wrong — say three Kennedys

Family members speak out as measles crisis grows

Michael Jonas

Senate budget stirs ire of MassBIO with drug pricing proposal

Coughlin calls Ways and Means approach ‘radical, unproven policy’

Andy Metzger

April 24, 2019

Juul says it’s only here to help

E-cigarette maker ad blitz comes as new risks emerge

Michael Jonas

Coughlin changes hats at hearing on drug pricing

Pharmaceutical pricing legislation picking up steam

Bruce Mohl

NJ doc disciplined for prescription scam

He never met Mass. patients, usually didn’t even talk to them

Colman M. Herman

Was ‘Reefer Madness’ right?

Alex Berenson says we’re ignoring the dangers of marijuana

Michael Jonas

Hail to the Harm Reduction Commission

By backing supervised drug consumption sites, they voted to save lives

Mark Eisenberg

State shouldn’t define pharmaceutical ‘value’

Baker drug-pricing proposal is shortsighted

Leslie Wood

June 5, 2018

Commission torn over supervised injection sites

As feds loom in background, Walsh favors them, Sudders wary

Andy Metzger

Cost of drugs in the US is an outrage

The blame game, and the emerging consensus to take action

Edward M Murphy

SJC weighs appropriate penalty for supplying heroin

Defense attorney argues to overturn manslaughter conviction

Andy Metzger

Baker’s Orwellian drug pricing policy

AG referral is the criminalization of a policy dispute

William Smith

Pharma faces different type of drug trial

Healey suing Purdue, Lelling prosecuting Insys

Andy Metzger

Baker backs rate-setting for high-cost drugs

Proposal gives roles to Health Policy Commission, AG

Bruce Mohl

Four reasons medication-assisted treatment may not help inmates

It's not clear providing opioid medications to prisoners is always the best course

Andrew Klein

We need better tools to control pharma prices

With many drug makers facing no competition, the market isn't working

Marylou Sudders

Spoon Movement comes to Beacon Hill

Heroin sculpture draws attention to pharma 'lies, deception'

Amanda Middle

Taming MassHealth drug costs

State should explore 'value-based' purchasing

William Smith

E-scripts for opioids save lives

Technology exists for officials to pass laws to stem the crisis

Jack Sullivan

Do your job, lawmakers tell pot agency

Rep expresses concern about commission's sense of urgency

Amanda Middle

Opioids’ path of destruction in construction

Sector accounts for one-quarter of all overdose deaths

Michael Jonas

Feds reject Baker bid to rein in pharmacy costs

State sought to restrict access to some MassHealth drugs

Bruce Mohl